Cargando…
MEDB-45. Functional genomics identifies epigenetic regulators as novel therapeutic targets for sonic hedgehog medulloblastoma
Medulloblastoma (MB) is among the most common malignant childhood brain tumors that comprises a group of four molecularly distinct diseases. A significant proportion of these tumors is characterized by aberrant activation of the canonical sonic hedgehog (SHH) signaling pathway. Although small-molecu...
Autores principales: | Tsiami, Foteini, Piccioni, Federica, Root, David, Bandopadhayay, Pratiti, Segal, Rosalind, Tabatabai, Ghazaleh, Merk, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165027/ http://dx.doi.org/10.1093/neuonc/noac079.419 |
Ejemplares similares
-
MEDB-57.GNAS inactivation as a driver for sonic hedgehog-activated medulloblastoma
por: Goode, Erin, et al.
Publicado: (2022) -
MEDB-52. Organoids as preclinical models to improve and personalize disease outcome for sonic hedgehog medulloblastoma
por: Odé, Zelda, et al.
Publicado: (2022) -
MEDB-02. The identification and functional characterization of circular RNA Circ_63706 in sonic hedgehog medulloblastomas
por: Pokhrel, Rudramani, et al.
Publicado: (2022) -
MEDB-73. Lipid metabolism as a therapeutic vulnerability in BET inhibitor-resistant medulloblastoma
por: Lupien, Leslie, et al.
Publicado: (2022) -
MEDB-85. Transcriptional complexes as resistance drivers to BET inhibition
por: Boynton, Adam, et al.
Publicado: (2022)